Labcorp LH
Labcorp Holdings Inc. · NYSE · Services-Medical Laboratories
Price, last 47 sessions
Our coverage
Nothing published yet.
Insider buying and selling
| Date | Insider | Trade | Shares | Avg. price | Value |
|---|---|---|---|---|---|
| Aug. 17, 2026 | Kerrii B. Anderson director | Sold 10b5-1 plan | 3,000 | $318.02 | $954,060 |
| Aug. 11, 2026 | Adam H. Schechter President & CEO, director | Sold 10b5-1 plan | 4,669 | $320.37 | $1.50 million |
| Aug. 4, 2026 | Amy B. Summy EVP, Chief Marketing Officer | Sold | 924 | $306.74 | $283,428 |
| Aug. 3, 2026 | Peter J. Wilkinson SVP, Chief Accounting Officer | Sold | 1,420 | $309.23 $309.22-$309.23 | $439,107 |
Open-market purchases and sales reported on SEC Form 4 filed since July 24, 2026; grants, option exercises and shares withheld for tax aren't shown. A trade under a 10b5-1 plan was scheduled in advance. Where a filing was amended, the amendment's figures are shown.
Recent SEC filings
All 18 →Results of operations and financial condition · Financial statements and exhibits
AI summary, unreviewedLabcorp beats Q3 2026 adjusted EPS consensus with $4.78 vs $4.64 and raises full-year adjusted EPS guidance to $18.30-$18.70
Regulation FD disclosure · Financial statements and exhibits
AI summary, unreviewedLabcorp Holdings Declares $0.72 Quarterly Cash Dividend Payable December 11, 2026
Regulation FD disclosure · Financial statements and exhibits
Regulation FD disclosure
Regulation FD disclosure · Financial statements and exhibits